Century Therapeutics, Inc. IPSC 深 沪
等待开盘 09-01 09:30:00 美东时间
2.05
+0.025
+1.23%
华盛通- 最 高2.06
- 今 开2.00
- 成交量 37.31万股
- 最 低 1.97
- 昨 收 2.025
- 总市值 3.71亿
- 52周最高 3.04
- 市盈率 静 --
- 换手率 0.21%
- 52周最低 0.435
- 委 比 23.65%
- 总股本 1.81亿
- 历史最高 32.899
- 量 比 0.79
- 振 幅 4.44%
- 历史最低 0.3418
- 每 手 1
- 风险率 0.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Century Therapeutics Q2 EPS $(0.17) Misses $(0.14) Estimate
Century Therapeutics (NASDAQ:IPSC) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 55.26 percent increase over losses of $(0.38) per share from the same period last year.
08-12 20:05
Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday
U.S. stocks were slightly lower, with the Dow Jones index falling around 0.1% on Friday. Shares of Apogee Enterprises Inc (NASDAQ:APOG) rose sharply after the company reported better-than-expected first-quarter financial results. Adjusted diluted earnings came in at 57 cents per share, topping the a...
06-26 22:18
Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures rise, Nasdaq up 1%. Graham Corp shares down 8.7%. Other stocks declining in pre-market trading: BVC, TLK, INDP, APPN, WIX, KB, SSSS, IPSC, AMPL, ICCM, SBSW, ROMA.
06-08 20:04
美股大行评级 | 潜在涨幅99.91%！Tigress Financial上调英伟达目标价至425美元，维持"强力买入"评级
今日重点评级关注：Tigress Financial：维持英伟达"强力买入"评级，目标价从360美元升至425美元；康托·菲茨杰拉德：维持DeFi Development"超配"评级，目标价从6美元升至7美元
05-28 19:00
Abercrombie & Fitch Upbeat Q1 Earnings, Joins Digital Turbine, Dycom Industries And Other Big Stocks Moving Higher On Wednesday
Dow Jones up 300 points with gains from Abercrombie & Fitch, Digital Turbine, Dycom Industries, Qfin Holdings, Editas Medicine, and others.
05-27 22:51
Lowe's, ZTO Express, Viavi Solutions And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
US stock futures higher, Lowe's shares fall after reporting earnings. Other stocks declining in pre-market trading. Photo via Shutterstock
05-20 20:05
Century Therapeutics Q1 EPS $(0.11) Beats $(0.17) Estimate
Century Therapeutics (NASDAQ:IPSC) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.17) by 31.25 percent. This is a 112.36 percent decrease over earnings of $0.89 per share
05-13 20:20
Century Therapeutics To Highlight CNTY-813, iPSC-Derived Islet Cell Replacement Therapy Program Engineered With Allo-Evasion 5.0 For Patients With Type 1 Diabetes At ADA 86th Scientific Sessions
Century Therapeutics, Inc. ((‘Century', NASDAQ:IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes, and cancer, today
05-01 04:27
美股大行评级 | 瑞银大幅上调西部数据、希捷科技目标价！汇丰银行上调英特尔评级至"买入"，目标价从50美元升至95美元
今日重点评级关注：HC Wainwright & Co.：维持Century Therapeutics"买入"评级，目标价从2美元升至5美元；Oppenheimer：维持Climb Bio"跑赢大市"评级，目标价从10美元升至18美元
04-22 12:41
Arrowhead Pharmaceuticals To Rally Over 44%? Here Are 10 Top Analyst Forecasts For Tuesday
Wall Street analysts update ratings on top names. B of A Sec raised CMS Energy Corp's price target to $88, Goldman Sachs raised Ramaco Resources Inc's target to $15, Truist Sec cut Packaging Corp's target to $260, Baird cut Mohawk Industries Inc's target to $118, Needham raised Crocs Inc's target to $132, HC Wainwright raised Century Therapeutics Inc's target to $5, and Morgan Stanley raised Arrowhead Pharmaceuticals Inc&#
04-21 19:56
